š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Lung allograft recipients have a higher burden of influenza disease and gre...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-11-08
Trial ID
NCT05215327
A phase I trial conducted in a single centre, observer-blind, randomized, d...
Status
Completed
Location
Canadian Science Centre for Human and Animal Health
Start Date
2013-12
Trial ID
NCT02022163
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
In solid organ transplant (SOT) the receipt of influenza vaccine in an infl...
Status
Completed
Location
University of Minnesota
Start Date
2023-09-11
Trial ID
NCT05663463
Treatments Being Tested
The purpose of this study is to learn about how the flu and COVID vaccines ...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2025-02-10
Trial ID
NCT06821061
The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...
Status
Completed
Location
CenExel CNS- Site Number : 8400005
Start Date
2024-11-04
Trial ID
NCT06641180
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01691339
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02563093
This pilot research trial studies the antibody response to high-dose season...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-10-17
Trial ID
NCT04484532
Treatments Being Tested